fashion -WSS

fashion

author：Wikipedia 2025-08-12 06:44:34 - browse：5486

Christine Kao/STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies.

PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves. So when new market developments threaten to diminish or wipe away that revenue stream, PBMs find crafty ways to keep as much of those dollars as possible — often at the expense of employers.

One such case occurred last year, when a wave of Humira biosimilars entered the market and drug companies slashed the list prices of their insulin products. CVS Caremark, the PBM owned by CVS Health that oversees the prescription drug benefits of 103 million people, told its employer clients that it anticipated “more lower-cost products (including specialty biosimilars) may become preferred products” on its lists of approved drugs for 2024, according to documents obtained by STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Assistant physicians can help address the primary care shortage

entertainment

WSS

FDA scientists endorse Pfizer/BioNTech Covid

'A game

A controversial new treatment promises to make little people taller

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Group behind ProMed defends move to subscription

'A game

hotspot

fashion

focus

Virginia high school admissions case could be legal follow

FDA weighs limits of animal data in assessing artificial wombs

Continuity nursing helped my family in our darkest PICU moments

It costs an awful lot of money to give away a kidney

Duchenne breakthrough therapy leaves behind pioneering families

Group behind ProMed defends move to subscription

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

When waiting feels immoral: Empathy in the emergency department

Guidelines to prevent youth baseball injuries need more muscle

FDA weighs limits of animal data in assessing artificial wombs

knowledge

Fed up with FDA, ALS advocates consider a take

CDC recommends RSV monoclonal antibody for infants

H.R. 3 is the wrong path to lower drug costs

Chamber of Commerce, DOJ clash in court over drug prices

How to ethically and practically extend health care to all

Information blocking fines are now fair game in health care

Wikipedia

leisure time

entertainment

entertainment